Masayuki Kobayashi
Direttore/Membro del Consiglio presso OTSUKA HOLDINGS CO., LTD.
Profilo
Masayuki Kobayashi is currently the Chairman at Taiho Oncology, Inc. since 2014, the President & Representative Director at Taiho Pharmaceutical Co., Ltd.
since 2012, and a Director at Otsuka Holdings Co., Ltd.
since 2017.
He previously served as the Chief Executive Officer at Otsuka America, Inc.
Posizioni attive di Masayuki Kobayashi
| Società | Posizione | Inizio |
|---|---|---|
| OTSUKA HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 30/03/2017 |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Presidente | 03/04/2012 |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Presidente | 01/04/2014 |
Precedenti posizioni note di Masayuki Kobayashi
| Società | Posizione | Fine |
|---|---|---|
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Presidente | 31/03/2012 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OTSUKA HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Health Technology |
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Masayuki Kobayashi
